✦ LIBER ✦

Intraperitoneal immunotherapy of epithelial ovarian carcinoma with Corynebacterium parvum

✍ Scribed by Berek, Jonathan S.; Knapp, Robert C.; Hacker, Neville F.; Lichtenstein, Alan; Jung, Tyler; Spina, Celsa; Obrist, R.; Griffiths, C.Thomas; Berkowitz, Ross S.; Parker, Leroy; Zighelboim, Jacob; Bast, Robert C.

Book ID: 122198715
Publisher: Elsevier Science
Year: 1985
Tongue: English
Weight: 782 KB
Volume: 152
Category: Article
ISSN: 1097-6868
DOI: 10.1016/0002-9378(85)90548-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intraperitoneal chemotherapy for women w

Intraperitoneal chemotherapy for women with advanced epithelial ovarian carcinoma

✍ Edward L. Trimble; Michaele C. Christian 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Intraperitoneal immunotherapy of human o

Intraperitoneal immunotherapy of human ovarian carcinoma with recombinant interferon: A phase I toxicity/immunopharmacology study

✍ J. Berek; N. Hacker; A. Lichtenstein; T. Jung; R. Knox; T. Greene; E. Bonnem; L. 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Active specific immunotherapy of mouse m

Active specific immunotherapy of mouse methylcholanthrene induced tumours with Corynebacterium parvum and irradiated tumour cells

✍ Bomford, R 📂 Article 📅 1975 🏛 Nature Publishing Group 🌐 English ⚖ 870 KB

Lack of effect of immunotherapy with BCG

Lack of effect of immunotherapy with BCG and Corynebacterium parvum on hepatic drug hydroxylation in man

✍ Wan, H H; Thatcher, N; Mullen, P W; Smith, G N; Wilkinson, P M 📂 Article 📅 1979 🏛 Nature Publishing Group 🌐 English ⚖ 527 KB

Intraperitoneal administration of coryne

Intraperitoneal administration of corynebacterium parvum in patients with ascitic ovarian tumors resistant to chemotherapy: Effects on cytotoxicity of tumor-associated macrophages and NK cells

✍ Alberto Mantovani; Cristiana Sessa; Giuseppe Peri; Paola Allavena; Martino Intro 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 French ⚖ 921 KB

## Abstract Eight ovarian cancer patients with ascites resistant to various chemotherapy protocols were treated i.p. with __C. parvum__ in an effort to obtain a palliative reduction of peritoneal effusions. __C. parvum__(7–14 mg) was given i.p. on days 0, 7, 28 and then at monthly intervals. Three

Modulation of hematoporphyrin derivative

Modulation of hematoporphyrin derivative-sensitized phototherapy with corynebacterium parvum in murine transitional cell carcinoma

✍ R.Craig Myers; Benjamin H.S. Lau; Dale Y. Kunihira; Robert R. Torrey; James L. W 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 664 KB